• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BaiCD 基因簇丰度与艰难梭菌感染呈负相关。

BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.

机构信息

Hannover Medical School, Institute of Medical Microbiology and Hospital Epidemiology, Hannover, Germany.

Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany.

出版信息

PLoS One. 2018 May 8;13(5):e0196977. doi: 10.1371/journal.pone.0196977. eCollection 2018.

DOI:10.1371/journal.pone.0196977
PMID:29738579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5940204/
Abstract

BACKGROUND

Clostridium difficile infection (CDI) is a major cause of hospital-acquired diarrhea. Secondary bile acids were shown to confer resistance to colonization by C. difficile. 7α-dehydroxylation is a key step in transformation of primary to secondary bile acids and required genes have been located in a single bile acid-inducible (bai) operon in C. scindens as well as in C. hiranonis, two Clostridium sp. recently reported to protect against C. difficile colonization.

AIM

To analyze baiCD gene abundance in C. difficile positive and negative fecal samples.

MATERIAL & METHODS: A species-specific qPCR for detecting baiCD genes was established. Fecal samples of patients with CDI, asymptomatic toxigenic C. difficile colonization (TCD), non-toxigenic C. difficile colonization (NTCD), of C. difficile negative (NC) patients, and of two patients before and after fecal microbiota transplantation (FMT) for recurrent CDI (rCDI) were tested for the presence of the baiCD genes.

RESULTS

The prevalence of the baiCD gene cluster was significantly higher in C. difficile negative fecal samples than in samples of patients diagnosed with CDI (72.5% (100/138) vs. 35.9% (23/64; p<0.0001). No differences in baiCD gene cluster prevalence were seen between NC and NTCD or NC and TCD samples. Both rCDI patients were baiCD-negative at baseline, but one of the two patients turned positive after successful FMT from a baiCD-positive donor.

CONCLUSION

Fecal samples of CDI patients are less frequently baiCD-positive than samples from asymptomatic carriers or C. difficile-negative individuals. Furthermore, we present a case of baiCD positivity observed after successful FMT for rCDI.

摘要

背景

艰难梭菌感染(CDI)是医院获得性腹泻的主要原因。次级胆汁酸被证明可以抵抗艰难梭菌的定植。7α-脱羟化是将初级胆汁酸转化为次级胆汁酸的关键步骤,所需基因已在 C. scindens 中的单个胆汁酸诱导(bai)操纵子以及最近报道可预防艰难梭菌定植的 C. hiranonis 中定位。

目的

分析 CDI 阳性和阴性粪便样本中 baiCD 基因的丰度。

材料和方法

建立了用于检测 baiCD 基因的种特异性 qPCR。检测了 CDI 患者、无症状产毒艰难梭菌定植(TCD)、非产毒艰难梭菌定植(NTCD)、艰难梭菌阴性(NC)患者以及 2 例复发性 CDI(rCDI)粪便微生物群移植(FMT)前后的粪便样本中 baiCD 基因的存在。

结果

baiCD 基因簇在 CDI 阴性粪便样本中的流行率明显高于诊断为 CDI 的患者样本(72.5%(100/138)比 35.9%(23/64;p<0.0001)。NC 和 NTCD 或 NC 和 TCD 样本之间 baiCD 基因簇流行率无差异。2 例 rCDI 患者基线时均为 baiCD 阴性,但其中 1 例在成功接受来自 baiCD 阳性供体的 FMT 后转为阳性。

结论

CDI 患者的粪便样本 baiCD 阳性率低于无症状携带者或艰难梭菌阴性个体的样本。此外,我们报告了 1 例 rCDI 成功 FMT 后 baiCD 阳性的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/32d9b5203f73/pone.0196977.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/d241a91dd6b9/pone.0196977.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/dc0c0fe68105/pone.0196977.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/47455ae555a9/pone.0196977.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/32d9b5203f73/pone.0196977.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/d241a91dd6b9/pone.0196977.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/dc0c0fe68105/pone.0196977.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/47455ae555a9/pone.0196977.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53b/5940204/32d9b5203f73/pone.0196977.g004.jpg

相似文献

1
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.BaiCD 基因簇丰度与艰难梭菌感染呈负相关。
PLoS One. 2018 May 8;13(5):e0196977. doi: 10.1371/journal.pone.0196977. eCollection 2018.
2
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent infection.微生物胆汁盐水解酶介导粪菌移植治疗复发性感染的疗效。
Gut. 2019 Oct;68(10):1791-1800. doi: 10.1136/gutjnl-2018-317842. Epub 2019 Feb 11.
3
Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.微生物群移植可恢复复发性艰难梭菌感染患者的正常粪便胆汁酸组成。
Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G310-9. doi: 10.1152/ajpgi.00282.2013. Epub 2013 Nov 27.
4
Strain-Dependent Inhibition of Clostridioides difficile by Commensal Carrying the Bile Acid-Inducible () Operon.依赖于应变的共生菌携带胆汁酸诱导()操纵子对艰难梭菌的抑制作用。
J Bacteriol. 2020 May 11;202(11). doi: 10.1128/JB.00039-20.
5
Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.复发性艰难梭菌感染粪菌移植后革兰氏阴性菌属种类变化和抗菌药物敏感性
mSphere. 2020 Oct 14;5(5):e00853-20. doi: 10.1128/mSphere.00853-20.
6
Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.粪便微生物移植增加复发性艰难梭菌患者结肠中的 IL-25 并抑制组织炎症。
mSphere. 2021 Oct 27;6(5):e0066921. doi: 10.1128/mSphere.00669-21.
7
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.完全微生物群植入对于粪便微生物群移植后复发性艰难梭菌感染的恢复并非必不可少。
mBio. 2016 Dec 20;7(6):e01965-16. doi: 10.1128/mBio.01965-16.
8
Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.粪便微生物群移植成功治疗艰难梭菌感染
J Physiol Pharmacol. 2016 Dec;67(6):859-866.
9
Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.经封装粪便微生物群移植治疗艰难梭菌感染后持久的长期细菌定植。
mBio. 2019 Jul 23;10(4):e01586-19. doi: 10.1128/mBio.01586-19.
10
Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study.微生物群相关的艰难梭菌获得风险因素在住院患者中:一项前瞻性、多中心研究。
Clin Infect Dis. 2021 Nov 2;73(9):e2625-e2634. doi: 10.1093/cid/ciaa871.

引用本文的文献

1
Host origin of microbiota drives functional recovery and clearance in mice.微生物群的宿主来源驱动小鼠的功能恢复和清除。
mBio. 2025 Jun 2:e0110825. doi: 10.1128/mbio.01108-25.
2
Clostridium scindens: history and current outlook for a keystone species in the mammalian gut involved in bile acid and steroid metabolism.斯氏梭菌:参与胆汁酸和类固醇代谢的哺乳动物肠道关键物种的历史与当前展望
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf016.
3
A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH.

本文引用的文献

1
Probiotics for prevention of Clostridium difficile infection.用于预防艰难梭菌感染的益生菌
Curr Opin Gastroenterol. 2018 Jan;34(1):3-10. doi: 10.1097/MOG.0000000000000410.
2
Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.肠道微生物群衍生的次级胆汁酸对临床相关艰难梭菌菌株孢子萌发、生长和毒素活性的抑制作用。
Anaerobe. 2017 Jun;45:86-100. doi: 10.1016/j.anaerobe.2017.03.004. Epub 2017 Mar 6.
3
European consensus conference on faecal microbiota transplantation in clinical practice.
一种不依赖肠道微生物群的机制塑造了患有MASH的小鼠的胆汁酸池。
JHEP Rep. 2024 Jun 20;6(11):101148. doi: 10.1016/j.jhepr.2024.101148. eCollection 2024 Nov.
4
A quantitative PCR to detect non-toxigenic .一种用于检测非产毒型的定量聚合酶链反应。
Microbiol Spectr. 2025 Jan 7;13(1):e0160824. doi: 10.1128/spectrum.01608-24. Epub 2024 Dec 11.
5
Bile acids impact the microbiota, host, and dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics.胆汁酸影响微生物群、宿主和动态,为深入了解 FMT 和专注于微生物组的治疗方法的疗效机制提供了线索。
Gut Microbes. 2024 Jan-Dec;16(1):2393766. doi: 10.1080/19490976.2024.2393766. Epub 2024 Sep 3.
6
The Potential of Bile Acids as Biomarkers for Metabolic Disorders.胆汁酸作为代谢紊乱生物标志物的潜力。
Int J Mol Sci. 2023 Jul 28;24(15):12123. doi: 10.3390/ijms241512123.
7
Treatment issues in recurrent infections and the possible role of germinants.复发性感染的治疗问题及萌发剂的可能作用。
FEMS Microbes. 2020 Sep 23;1(1):xtaa001. doi: 10.1093/femsmc/xtaa001. eCollection 2020 Sep.
8
infection: microbe-microbe interactions and live biotherapeutics.感染:微生物-微生物相互作用与活体生物治疗剂
Front Microbiol. 2023 May 9;14:1182612. doi: 10.3389/fmicb.2023.1182612. eCollection 2023.
9
Defecation status, intestinal microbiota, and habitual diet are associated with the fecal bile acid composition: a cross-sectional study in community-dwelling young participants.排便状态、肠道微生物群和习惯性饮食与粪便胆汁酸组成有关:一项在社区居住的年轻参与者中的横断面研究。
Eur J Nutr. 2023 Aug;62(5):2015-2026. doi: 10.1007/s00394-023-03126-8. Epub 2023 Mar 7.
10
Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.粪便微生物群移植治疗复发性艰难梭菌感染和/或炎症性肠病的宏基因组学和胆汁酸代谢组学分析
Med Res Arch. 2022 Oct 31;10(10). doi: 10.18103/mra.v10i10.3318.
临床实践中粪便微生物群移植欧洲共识会议
Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13.
4
Functional Intestinal Bile Acid 7α-Dehydroxylation by Associated with Protection from Infection in a Gnotobiotic Mouse Model.在悉生小鼠模型中,功能性肠道胆汁酸7α-脱羟基作用与抵御感染相关。
Front Cell Infect Microbiol. 2016 Dec 20;6:191. doi: 10.3389/fcimb.2016.00191. eCollection 2016.
5
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.粪便过滤移植治疗艰难梭菌感染的疗效。
Gastroenterology. 2017 Mar;152(4):799-811.e7. doi: 10.1053/j.gastro.2016.11.010. Epub 2016 Nov 17.
6
Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.无症状但艰难梭菌毒素呈阳性?老年住院患者中产毒艰难梭菌携带者的患病率及危险因素
BMC Geriatr. 2016 Nov 15;16(1):185. doi: 10.1186/s12877-016-0358-3.
7
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment.产肠毒素大肠杆菌攻击及随后环丙沙星治疗后人类肠道微生物群的个体特异性变化。
BMC Genomics. 2016 Jun 8;17:440. doi: 10.1186/s12864-016-2777-0.
8
Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.抗生素诱导的肠道微生物群改变会改变次级胆汁酸的产生,并允许艰难梭菌孢子在大肠中发芽和生长。
mSphere. 2016 Jan 6;1(1). doi: 10.1128/mSphere.00045-15. eCollection 2016 Jan-Feb.
9
Consequences of bile salt biotransformations by intestinal bacteria.肠道细菌对胆盐生物转化的后果。
Gut Microbes. 2016;7(1):22-39. doi: 10.1080/19490976.2015.1127483.
10
Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.粪便微生物群移植后结肠胆汁酸组成的变化足以控制艰难梭菌的萌发和生长。
PLoS One. 2016 Jan 20;11(1):e0147210. doi: 10.1371/journal.pone.0147210. eCollection 2016.